Q1 2025

Filed May 14, 2025 · 10-Q · 44 days after period end · 0001663577-25-000136

Q1 2025 · 10-Q

Revenue

$5.00K

±0.0% vs Q1 2024

Net Income

-$281.01K

N/M vs Q1 2024

EPS, diluted—

Gross Profit$5,000±0.0%

Operating Income-$139,852N/M

Same quarter

Metric	Q1 2025	Q1 2024	Q1 2023	Q1 2022
Revenue	$5.00K	$5.00K	$5.00K	$59.98K
Net Income	-$281.01K	-$290.37K	-$1.52M	-$214.52K
EPS Diluted	—	-$0.06	-$0.33	-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR